CSIMarket
 
Bausch Health Companies Inc   (NYSE: BHC)
 

Bausch Health Companies Inc's Suppliers Performance

BHC's Supply Chain




 
BHC Costs vs Sales of Suppliers Growth Bausch Health Companies Inc recorded an increase in cost of sales by 106.42 % year on year, sequentially cost of sales grew by 114.15 % in Q2.

• More on BHC Suppliers



Bausch Health Companies Inc recorded increase in cost of sales by 106.42 % year on year, sequentially cost of sales grew by 114.15 % in Q2.

• More on BHC Suppliers




Bausch Health Companies Inc's Comment on Supply Chain


Bausch Health Companies Inc. obtains principal raw materials, including active pharmaceutical ingredients, from the open market or multiple sources. Certain active pharmaceutical ingredients, other raw materials, and finished products for key products such as Lumify®, Vyzulta®, SofLens®, MIEBO®, XIIDRA®, Wellbutrin XL®, Relistor® injection, Trulance®, Jublia®, Aplenzin®, Arestin®, Bedoyecta®, Siliq®, and PureVision® are currently sourced from a single supplier, which may be an internal manufacturing site or a third-party manufacturer. The company addresses risks associated with single-source reliance by maintaining additional inventories or developing alternative sources when feasible. Disruptions or cost increases related to these single-sourced materials could negatively impact manufacturing, supply, or profitability.

Bausch Health Companies Inc's Comment on Supply Chain


Bausch Health Companies Inc. obtains principal raw materials, including active pharmaceutical ingredients, from the open market or multiple sources. Certain active pharmaceutical ingredients, other raw materials, and finished products for key products such as Lumify®, Vyzulta®, SofLens®, MIEBO®, XIIDRA®, Wellbutrin XL®, Relistor® injection, Trulance®, Jublia®, Aplenzin®, Arestin®, Bedoyecta®, Siliq®, and PureVision® are currently sourced from a single supplier, which may be an internal manufacturing site or a third-party manufacturer. The company addresses risks associated with single-source reliance by maintaining additional inventories or developing alternative sources when feasible. Disruptions or cost increases related to these single-sourced materials could negatively impact manufacturing, supply, or profitability.







BHC's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Bausch Health Companies Inc 2,136.27 10,853.00 -1,093.00 20,300
SUBTOTAL 0.00 0.00 0.00 -


Sources: Bausch Health Companies Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Bausch Health Companies Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.